Abstract

COMPARATIVE STUDY ON FORMULATION OF MICONAZOLE AND NYSTATIN IN THE TREATMENT OF VAGINAL CANDIDIASIS

K. Gajalakshmi*, M. Praveen Kumar, M. Vijayalakshmi, V. Krishnan

Abstract

Vaginal candidiasis is one of the most common fungal infections affecting women, mainly caused by Candida albicans. It is often associated with symptoms such as vaginal itching, irritation, burning sensation, and abnormal discharge, which can significantly affect a woman’s comfort and quality of life. Effective antifungal therapy is therefore important for both symptom relief and prevention of recurrence. The present study focuses on the comparative evaluation of two commonly used antifungal drugs, miconazole and nystatin, formulated for the treatment of vaginal candidiasis. Miconazole is an imidazole antifungal agent that acts by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane. This disruption weakens the membrane and ultimately leads to the death of the fungal cells. Nystatin, on the other hand, is apolyene antifungal antibiotic that binds directly to ergosterol in the fungal membrane, creating pores that cause leakage of intracellular components and fungal cell destruction. Both drugs are widely available in vaginal dosage forms such as creams, tablets, and suppositories for local administration. This comparative study evaluates the effectiveness of the formulations based on parameters such as antifungal activity, symptom relief, patient tolerance, and recurrence of infection. Previous clinical observations indicate that both medications are effective in managing vaginal candidiasis. However, miconazole formulations may provide faster symptom relief and slightly higher cure rates, while nystatin remains a safe and reliable option with minimal systemic absorption and good patient tolerance. In conclusion, both miconazole and nystatin formulations are effective in the treatment of vaginal candidiasis. A comparative understanding of their formulation characteristics and therapeutic outcomes can help healthcare professionals select the most appropriate treatment option for better patient care.

Keywords: Miconazole is an imidazole antifungal agent that acts by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane.